Intended for healthcare professionals

Letters GPs’ uptake of new prescribing guidance

Dangers of selective NSAID prescribing in Quality and Outcomes Framework

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6697 (Published 28 November 2019) Cite this as: BMJ 2019;367:l6697
  1. Sheila Jackson, GP
  1. Barnoldswick Medical Centre, Barnoldswick BB18 5BG, UK
  1. sheila.jackson{at}nhs.net

Wallace highlights that the pace of change in healthcare is rapid and the implementation of new evidence into clinical practice is suboptimal.1

I hope that GP practices do not follow all the Quality and Outcomes Framework prescribing guidance given by NHS England in the 2019-20 General Medical Services contract as I am concerned about serious adverse consequences that may result from the …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription